Daratumumab Maintenance Shows Clinical Benefit in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma
Researchers sought to determine whether daratumumab maintenance therapy would be effective in patients with newly diagnosed multiple myeloma.